The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.
Analytical
testing helps in providing real-time product quality control along with
optimizing and monitoring processes, characterizing biosimilars and
biologics, and improving productivity. One of the main reasons for outsourcing
analytical testing services is to benefit from skilled and experienced
professionals, as well as to access expensive analytical equipment which are
not available in-house.
Increased
development of biologics is also creating a demand for analytical testing
services. In the last three decades, biologics have taken the center stage in
the discovery and development of drugs. Moreover, there is a high demand to
define higher-order biological structures. The need for better product
characterization, along with comparability studies, especially for biosimilars,
further leads to drug companies outsourcing these services.
A
patent cliff, particularly for small molecules in the pharmaceutical industry
leads to a decline in revenue, thereby affecting profits. Over the next few
years, several best-selling biologics would come toward the end of patent life,
such as Humira. Drug innovators are therefore under constant pressure to bring
new products through the pipeline at a faster rate. Developing advanced
analytical testing to assess and monitor the quality attributes of these
products requires a broader set of equipment and expertise, which is beyond the
internal capacity of pharma companies. This would subsequently lead to
increased instances of outsourcing pharmaceutical analytical testing
services.
Full Research Report On Pharmaceutical Analytical Testing Outsourcing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market
Pharmaceutical
Analytical Testing Outsourcing Market Report Highlights
- The outsourcing of clinical
bioanalytical testing services emerged as the largest segment in 2019 with
a share of around 79% owing to the increasing number of clinical trials
- The extractable and
leachable services segment is expected to witness a significant growth
rate owing to an increasing number of vendors offering these services at
competitive prices
- North America dominated the
global market with a share of 54.2% in 2019 as the region is one of the
top manufacturing hubs of highly reliable, complex, and high-end
pharmaceuticals
- Some of the players
operating in the pharmaceutical analytical testing outsourcing market are
Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston
Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services,
Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi
AppTec, Inc.; and Charles River Laboratories International, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market/request/rs1
Pharmaceutical
Analytical Testing Outsourcing Market Segmentation
Grand View Research has segmented
the global pharmaceutical analytical testing outsourcing market on the basis of
service and region:
Pharmaceutical
Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2016 -
2027)
- Bioanalytical Testing
- Clinical
- Non Clinical
- Method Development &
Validation
- Extractable & Leachable
- Impurity Method
- Technical Consulting
- Others
- Stability Testing
- Drug Substance
- Stability Indicating Method
Validation
- Accelerated Stability
- Photostability
- Others
- Others
Pharmaceutical
Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 -
2027)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Turkey
- Netherlands
- Switzerland
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Malaysia
- Singapore
- Thailand
- Taiwan
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Israel
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment